Clovis Oncology (CLVS) Misses Q3 EPS by 55c
Tweet
Share
E-mailGet Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($2.62), $0.55 worse than the analyst estimate of ($2.07).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
